Guggenheim Capital’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q2
Sell
-228,782
Closed -$39.5M 3183
2015
Q1
$39.5M Buy
228,782
+84,895
+59% +$14.7M 0.09% 393
2014
Q4
$16.5M Sell
143,887
-302,472
-68% -$34.8M 0.04% 678
2014
Q3
$69.7M Buy
446,359
+160,423
+56% +$25.1M 0.17% 103
2014
Q2
$35.3M Sell
285,936
-29,994
-9% -$3.7M 0.09% 378
2014
Q1
$32.7M Buy
315,930
+19,359
+7% +$2.01M 0.09% 334
2013
Q4
$26.7M Buy
296,571
+190,860
+181% +$17.2M 0.08% 402
2013
Q3
$7.07M Buy
105,711
+92,296
+688% +$6.17M 0.03% 942
2013
Q2
$887K Buy
+13,415
New +$887K ﹤0.01% 2061